LGND

Ligand Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality6/10
  • Growth↓ 0/10
  • Momentum↑ 7/10
Ligand Pharmaceuticals sales and earnings growth
LGND Growth
Low
  • Revenue Y/Y↑ 64.83%
  • EPS Y/Y↓ -12.50%
  • FCF Y/Y↓ -59.05%
Ligand Pharmaceuticals gross and profit margin trends
LGND Profitability
Great
  • Gross margin ↑ 94.30%
  • EPS margin↑ 19.30%
  • ROIC↓ 9.50%
Ligand Pharmaceuticals net debt vs free cash flow
LGND Risk
Great
  • Debt / Equity↓ 0.5
  • Debt / FCF↑ 10.1
  • Interest coverage↑ 17.5

Ligand Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗